Fig. 2From: Nomogram to predict survival of patients with advanced and metastatic pancreatic CancerChemotherapy response-based nomogram, used to predict 1-year and 2-year survival rate in patients with advanced and metastatic pancreatic cancer, created using five independent prognostic factorsBack to article page